Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ALVARO J ALENCAR

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1417159633
CMS profile
1171980
Location
MIAMI, FL

General Payments · PY2019–2025

$140,382.47

  • Reported across 121 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$65,832.90

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $50,765.08 13
BeOne Medicines USA, Inc. $4,852.14 5
Acerta Pharma LLC $2,920.00 2
Incyte Corporation $2,857.61 6
Deciphera Pharmaceuticals Inc. $2,480.00 1
ABBVIE INC. $1,800.00 3
Genentech USA, Inc. $84.46 2
ADC THERAPEUTICS AMERICA, INC. $73.61 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $11,327.51 27
PY2020 $1,863.57 3
PY2021 $18,262.08 15
PY2022 $7,832.00 5
PY2023 $10,957.85 12
PY2024 $24,306.56 26
PY2025 $65,832.90 33

Payment records · PY2025 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $1,200.00 04/15/2025 Consulting Fee Undisputed 06/30/2026 1201391956 CMS
ABBVIE INC. $300.00 06/23/2025 Consulting Fee Undisputed 06/30/2026 1201391958 CMS
ABBVIE INC. $300.00 09/22/2025 Consulting Fee Undisputed 06/30/2026 1201391960 CMS
ADC THERAPEUTICS AMERICA, INC. $73.61 06/19/2025 Food and Beverage Undisputed 06/30/2026 1246113468 CMS
AstraZeneca Pharmaceuticals LP $50.00 12/05/2025 Food and Beverage Undisputed 06/30/2026 1206154678 CMS
AstraZeneca Pharmaceuticals LP $2,870.00 12/16/2025 Consulting Fee Undisputed 06/30/2026 1206607273 CMS
BeOne Medicines USA, Inc. $38.22 03/19/2025 Food and Beverage Undisputed 06/30/2026 1202887438 CMS
BeOne Medicines USA, Inc. $4,550.00 04/01/2025 Consulting Fee Undisputed 06/30/2026 1202887440 CMS
BeOne Medicines USA, Inc. $53.75 04/01/2025 Consulting Fee Undisputed 06/30/2026 1202887442 CMS
BeOne Medicines USA, Inc. $61.29 06/19/2025 Food and Beverage Undisputed 06/30/2026 1202887436 CMS
BeOne Medicines USA, Inc. $148.88 12/05/2025 Food and Beverage Undisputed 06/30/2026 1202887434 CMS
Deciphera Pharmaceuticals Inc. $2,480.00 12/23/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1235957909 CMS
Genentech USA, Inc. $53.18 06/19/2025 Food and Beverage Undisputed 06/30/2026 1211491547 CMS
Genentech USA, Inc. $31.28 12/06/2025 Food and Beverage Undisputed 06/30/2026 1211491549 CMS
Incyte Corporation $30.00 12/04/2025 Food and Beverage Undisputed 06/30/2026 1226028961 CMS
Incyte Corporation $455.63 12/04/2025 Travel and Lodging Undisputed 06/30/2026 1226028977 CMS
Incyte Corporation $161.00 12/04/2025 Travel and Lodging Undisputed 06/30/2026 1226029043 CMS
Incyte Corporation $140.00 12/04/2025 Food and Beverage Undisputed 06/30/2026 1226029103 CMS
Incyte Corporation $15.98 12/04/2025 Travel and Lodging Undisputed 06/30/2026 1226029113 CMS
Incyte Corporation $2,055.00 12/18/2025 Consulting Fee Undisputed 06/30/2026 1226029007 CMS
Lilly USA, LLC $2,000.00 05/16/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1186506941 CMS
Lilly USA, LLC $11,400.00 05/19/2025 Consulting Fee Undisputed 06/30/2026 1186507401 CMS
Lilly USA, LLC $3,200.00 08/07/2025 Consulting Fee Undisputed 06/30/2026 1186494215 CMS
Lilly USA, LLC $145.80 09/26/2025 Travel and Lodging Undisputed 06/30/2026 1186473071 CMS
Lilly USA, LLC $173.30 09/26/2025 Travel and Lodging Undisputed 06/30/2026 1186506939 CMS
Lilly USA, LLC $104.98 09/26/2025 Travel and Lodging Undisputed 06/30/2026 1186509961 CMS
Lilly USA, LLC $4,000.00 09/29/2025 Consulting Fee Undisputed 06/30/2026 1186494211 CMS
Lilly USA, LLC $4,000.00 09/29/2025 Consulting Fee Undisputed 06/30/2026 1186508635 CMS
Lilly USA, LLC $11,400.00 09/30/2025 Consulting Fee Undisputed 06/30/2026 1186506943 CMS
Lilly USA, LLC $7,800.00 10/06/2025 Consulting Fee Undisputed 06/30/2026 1186494213 CMS
Lilly USA, LLC $6,400.00 10/06/2025 Consulting Fee Undisputed 06/30/2026 1186509963 CMS
Lilly USA, LLC $24.00 10/14/2025 Travel and Lodging Undisputed 06/30/2026 1186483491 CMS
Lilly USA, LLC $117.00 10/14/2025 Travel and Lodging Undisputed 06/30/2026 1186509965 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.